4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001013762-14-000263
$HURACIK 0001498382operating
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:34 PM ET
Size
14.8 KB
Accession
0001013762-14-000263
Insider Transaction Report
Form 4
Garner William J
Director
Transactions
- Sale
Common Stock
2014-03-18$1.30/sh−25,000$32,500→ 65,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 20,000 total - Sale
Common Stock
2014-03-18$1.30/sh−25,000$32,500→ 40,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 10,000 total - Sale
Common Stock
2014-03-18$1.30/sh−10,000$13,000→ 30,000 total - Conversion
Exchangeable Shares
2014-03-18$0.01/sh−80,000$400→ 2,513,541 total(indirect: See footnote)→ Common Stock (80,000 underlying) - Conversion
Common Stock
2014-03-18+80,000→ 90,000 total
Footnotes (3)
- [F1]Exchangeable Shares are shares of Exchangeco (as such terms are defined in the Issuer's Current Report on Form 8-K filed with the SEC on January 31, 2013) which are exchangeable on a 1-for-1 basis at any time for shares of common stock in the Issuer.
- [F2]Shares are held in trust by Jeffrey Bacha.
- [F3]5,000 shares are held by EGB Advisors, LLC, which is owned by Mr. Garner, and the remainder are held directly by Mr. Garner.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:34 PM ET
- Size
- 14.8 KB